1. Home
  2. IDYA vs HNI Comparison

IDYA vs HNI Comparison

Compare IDYA & HNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IDYA
  • HNI
  • Stock Information
  • Founded
  • IDYA 2015
  • HNI 1944
  • Country
  • IDYA United States
  • HNI United States
  • Employees
  • IDYA N/A
  • HNI N/A
  • Industry
  • IDYA Biotechnology: Pharmaceutical Preparations
  • HNI Office Equipment/Supplies/Services
  • Sector
  • IDYA Health Care
  • HNI Consumer Discretionary
  • Exchange
  • IDYA Nasdaq
  • HNI Nasdaq
  • Market Cap
  • IDYA 2.6B
  • HNI 2.1B
  • IPO Year
  • IDYA 2019
  • HNI N/A
  • Fundamental
  • Price
  • IDYA $26.64
  • HNI $54.89
  • Analyst Decision
  • IDYA Strong Buy
  • HNI Strong Buy
  • Analyst Count
  • IDYA 12
  • HNI 1
  • Target Price
  • IDYA $53.08
  • HNI $63.00
  • AVG Volume (30 Days)
  • IDYA 750.9K
  • HNI 348.1K
  • Earning Date
  • IDYA 11-04-2024
  • HNI 10-29-2024
  • Dividend Yield
  • IDYA N/A
  • HNI 2.40%
  • EPS Growth
  • IDYA N/A
  • HNI 159.58
  • EPS
  • IDYA N/A
  • HNI 2.56
  • Revenue
  • IDYA $3,922,000.00
  • HNI $2,563,700,000.00
  • Revenue This Year
  • IDYA N/A
  • HNI $5.42
  • Revenue Next Year
  • IDYA $158.10
  • HNI $2.73
  • P/E Ratio
  • IDYA N/A
  • HNI $21.40
  • Revenue Growth
  • IDYA N/A
  • HNI 10.36
  • 52 Week Low
  • IDYA $26.41
  • HNI $38.55
  • 52 Week High
  • IDYA $47.74
  • HNI $57.59
  • Technical
  • Relative Strength Index (RSI)
  • IDYA 33.96
  • HNI 57.53
  • Support Level
  • IDYA $27.52
  • HNI $54.29
  • Resistance Level
  • IDYA $32.67
  • HNI $57.59
  • Average True Range (ATR)
  • IDYA 1.44
  • HNI 1.35
  • MACD
  • IDYA -0.04
  • HNI 0.38
  • Stochastic Oscillator
  • IDYA 3.75
  • HNI 71.73

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations.

About HNI HNI Corporation

HNI Corp is a provider of office furniture and hearth products. The company generates the bulk of its revenue from its workplace furnishing, which consists of panel-based and freestanding furniture systems, seating, storage, tables, and architectural products. These products are sold through a national system of dealers, wholesalers, and office product distributors but also directly to end-user customers and federal, state, and local governments. Residential building products include a full array of gas, wood, electric, and pellet-fueled fireplaces, inserts, stoves, facings, and accessories. The company has operations in the United States, Canada, Mainland China, Hong Kong, India, Mexico, and Taiwan.

Share on Social Networks: